Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
COVIGEN
- Development stage
- Phase 1
- Lead developer
- Technovalia
- Modality
- DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
COVIGEN is a plasmid DNA-based vaccine candidate against SARS-CoV-2, developed by BioNet-Asia in collaboration with Technovalia as part of an Australian COVID-19 vaccine program. It encodes viral antigen sequences intended to induce protective humoral and cellular immune responses against COVID-19 and is delivered intramuscularly using PharmaJet’s Stratis needle-free jet injection system in early clinical studies.[4][10] Preclinical data showed acceptable safety and immunogenicity, leading to a Phase 1/1b trial in healthy adults to assess safety, tolerability, and immune responses as a potential prophylactic vaccine for COVID-19.[4][10]
- Brand names
- COVIGEN
- Other names
- BioNet SARS-CoV-2 DNA vaccineTechnovalia COVID-19 DNA vaccineSARS-CoV-2 DNA vaccineSARS-CoV2 DNA vaccineSARS-CoV 2 DNA vaccine
02
Targets
SARS-CoV-2 spike
Beyond the preview
Go deeper on COVIGEN.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on COVIGEN.